These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 2544482)

  • 21. Evidence of the protective immunogenicity of native and recombinant Clostridium haemolyticum phospholipase C (beta toxin) in guinea pigs.
    Hauer PJ; Yeary TJ; Rosenbusch RF
    Vaccine; 2006 Jan; 24(2):124-32. PubMed ID: 16140435
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunization of rabbits with recombinant Clostridium perfringens alpha toxins CPA-C and CTB-CPA-C in a bicistronic design expression system confers strong protection against challenge.
    Peng X; Peng G; Li X; Feng L; Dong L; Jiang Y
    Protein Expr Purif; 2020 Mar; 167():105550. PubMed ID: 31811913
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of Clostridium perfringens alpha-toxin (PLC) and perfringolysin O (PFO) on cytotoxicity to macrophages, on escape from the phagosomes of macrophages, and on persistence of C. perfringens in host tissues.
    O'Brien DK; Melville SB
    Infect Immun; 2004 Sep; 72(9):5204-15. PubMed ID: 15322015
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunization with an alphatoxin variant 121A/91-R212H protects mice against Clostridium perfringens alphatoxin.
    Schoepe H; Neubauer A; Schlapp T; Wieler LH; Baljer G
    Anaerobe; 2006 Feb; 12(1):44-8. PubMed ID: 16701610
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dissecting the contributions of Clostridium perfringens type C toxins to lethality in the mouse intravenous injection model.
    Fisher DJ; Fernandez-Miyakawa ME; Sayeed S; Poon R; Adams V; Rood JI; Uzal FA; McClane BA
    Infect Immun; 2006 Sep; 74(9):5200-10. PubMed ID: 16926413
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The C-terminal domain of Clostridium perfringens alpha toxin as a vaccine candidate against bovine necrohemorrhagic enteritis.
    Goossens E; Verherstraeten S; Valgaeren BR; Pardon B; Timbermont L; Schauvliege S; Rodrigo-Mocholí D; Haesebrouck F; Ducatelle R; Deprez PR; Van Immerseel F
    Vet Res; 2016 Apr; 47(1):52. PubMed ID: 27121298
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Measurement of Clostridium perfringens beta-toxin production by surface plasmon resonance immunoassay.
    Hsieh HV; Stewart B; Hauer P; Haaland P; Campbell R
    Vaccine; 1998; 16(9-10):997-1003. PubMed ID: 9682350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. On the in vitro neutralization test of Clostridium perfringens type A toxin.
    Shemanova GF; Vlasova EV; Postnikova TM
    J Hyg Epidemiol Microbiol Immunol; 1988; 32(2):219-26. PubMed ID: 2900852
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preparation and preliminary application of monoclonal antibodies to the receptor binding region of Clostridium difficile toxin B.
    Chen W; Liu WE; Li YM; Luo S; Zhong YM
    Mol Med Rep; 2015 Nov; 12(5):7712-20. PubMed ID: 26459027
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification and sequence determination of recombinant Clostridium perfringens alpha-toxin by use of electrospray ionization mass spectrometry.
    Saito H; Inoue M; Tomiki M; Nemoto H; Komoriya T; Kimata J; Watanabe K; Kohno H
    Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi; 2009; 20(1-2):9-20. PubMed ID: 20528092
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of Clostridium perfringens alpha toxin using a capture antibody ELISA.
    Hale ML; Stiles BG
    Toxicon; 1999 Mar; 37(3):471-84. PubMed ID: 10080352
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recombinant vaccinia viruses protect against Clostridium perfringens alpha-toxin.
    Bennett AM; Lescott T; Phillpotts RJ; Mackett M; Titball RW
    Viral Immunol; 1999; 12(2):97-105. PubMed ID: 10413356
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A genetically engineered vaccine against the alpha-toxin of Clostridium perfringens protects mice against experimental gas gangrene.
    Williamson ED; Titball RW
    Vaccine; 1993 Sep; 11(12):1253-8. PubMed ID: 8256506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced production of phospholipase C and perfringolysin O (alpha and theta toxins) in a gatifloxacin-resistant strain of Clostridium perfringens.
    Rafii F; Park M; Bryant AE; Johnson SJ; Wagner RD
    Antimicrob Agents Chemother; 2008 Mar; 52(3):895-900. PubMed ID: 18160514
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A field study of naturally occurring specific antibodies against Clostridium perfringens alpha toxin in Norwegian broiler flocks.
    Heier BT; Lovland A; Soleim KB; Kaldhusdal M; Jarp J
    Avian Dis; 2001; 45(3):724-32. PubMed ID: 11569751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beta toxin is essential for the intestinal virulence of Clostridium perfringens type C disease isolate CN3685 in a rabbit ileal loop model.
    Sayeed S; Uzal FA; Fisher DJ; Saputo J; Vidal JE; Chen Y; Gupta P; Rood JI; McClane BA
    Mol Microbiol; 2008 Jan; 67(1):15-30. PubMed ID: 18078439
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The production and evaluation of monoclonal antibodies to Clostridium perfringens type D epsilon toxin.
    Boarer CD; Sojka MG; White VJ; Roeder PL
    J Biol Stand; 1988 Jul; 16(3):207-18. PubMed ID: 2902095
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synergistic effects of alpha-toxin and perfringolysin O in Clostridium perfringens-mediated gas gangrene.
    Awad MM; Ellemor DM; Boyd RL; Emmins JJ; Rood JI
    Infect Immun; 2001 Dec; 69(12):7904-10. PubMed ID: 11705975
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dissociation of various biological activities of Clostridium perfringens alpha toxin by chemical modification.
    Sakurai J; Fujii Y; Torii K; Kobayashi K
    Toxicon; 1989; 27(3):317-23. PubMed ID: 2728024
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A quantitative electrochemiluminescence assay for Clostridium perfringens alpha toxin.
    Merrill GA; Rivera VR; Neal DD; Young C; Poli MA
    Anal Biochem; 2006 Oct; 357(2):181-7. PubMed ID: 16949539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.